In addition, HLA-I–/PD-L1– tumors had smaller size (T) than HLA-I–/PD-L1+ tumors (p < 0.008, Table 3), while the majority of HLA-I+/PD-L1– tumors (64%) were at the early stage I of cancer development (data not shown). The gene discussed is CD274; the disease is cancer.